0.85 USD
↗ 0.03 (4.15%)AT CLOSE (11:59 AM EDT)
Clearmind Medicine Inc. Common Shares
CMNDNASDAQ • USD
0.83
↘ 0.07 (8.20%)
POST MARKET (AS OF 06:22 PM EDT)
Post Market
AS OF 06:22 PM EDT
0.83
↘ 0.07 (8.20%)
Market: OPEN
Open?$0.75
High?$0.90
Low?$0.72
Prev. Close?$0.82
Volume?4.3M
Avg. Volume?N/A
VWAP?$0.79
Bid / Ask
Bid?$0.69 × 100
Ask?$0.97 × 100
Spread?$0.28
Midpoint?$0.83
Valuation & Ratios
Market Cap?2.0M
Shares Out?158.1K
Float?156.6K
Float %?99.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
News
Profile
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.